03/2022・Trifork Group – 2021 annual report and interim report for the quarter ending 31 December 2021

In This Article:

Trifork Holding AG
Trifork Holding AG

Company announcement no. 3 / 2022
Schindellegi, Switzerland – 16 March 2022


Trifork Group reports revenue growth of 37.4% for 2021 and 21.2% in Q4 2021

Financial year 2021

  • Trifork Group

    • In 2021, Trifork Group revenue amounted to EURm 158.5, an increase by 37.4% from EURm 115.4 in 2020. Organic growth of 19.6% was mainly driven by high level of activity in Digital Health in Denmark and Fintech in the UK. Inorganic growth of EURm 20.5 came from the acquisitions of Nine A/S in September 2020, Vilea Group in May 2021 and Strongminds ApS in November 2021.

    • Trifork Group EBITDA amounted to EURm 47.4. This included special items of EURm 22.1 from the deconsolidation of Dawn Health and IPO-preparation costs of EURm 1.8.

    • Trifork Group EBIT amounted to EURm 35.6 compared to EURm 6.4 in 2020.

    • Trifork Group net income was EURm 32.7 in 2021, compared to EURm 44.7 in 2020.

  • Trifork segment

    • In 2021, adjusted EBITDA of the Trifork segment amounted to EURm 28.6, an increase of 41.9% from EURm 20.2 in 2020. The adjusted EBITDA margin reached 18.1%, up from 17.5% in 2020.

    • Sub-segments

      • Trifork Inspire sub-segment revenue increased by 22.9% from EURm 1.9 to EURm 2.4., while adjusted EBITDA ended at EURm -0.6.

      • Trifork Build sub-segment revenue increased by 41.8% from EURm 86.7 to EURm 123.0 (EURm 20.5 inorganic) and realized an adjusted EBITDA margin of 21.2%.

      • Trifork Run sub-segment revenue increased by 23.6% (all organic) from EUR 26.4m to EURm 32.7, reflecting an adjusted EBITDA margin of 22.8%.

  • Trifork Labs

    • The positive fair value adjustment of Trifork Labs investments amounted to EURm 5.0. This was due to unrealized gains resulting from new financing rounds and dividends. In 2020, the positive fair value adjustement was EURm 41.3, mainly due to the exit of the investment in Humio Ltd., that was agreed in December 2020, with proceeds received in March 2021.


Q4 2021

  • Trifork Group

    • In Q4 2021, Trifork Group revenue amounted to EURm 42.3, an increase of 21.2% from EURm 34.9. Of this, EURm 41.4 was organic.

    • Trifork Group EBITDA amounted to EURm 29.2, including special items of EURm 22.1 from the deconsolidation of Dawn Health.

    • Trifork Group EBIT amounted to EURm 26.1 compared to EURm 1.2 in 2020.

    • Trifork Group Q4 2021 net income amounted to EURm 24.5 compared to EURm 40.8 in Q4 2020.

  • Trifork Segment

    • In Q4 2021, adjusted EBITDA of the Trifork segment amounted to EURm 7.4, a decrease of 2.2% from EURm 7.5 in Q4 2020, corresponding to an adjusted EBITDA margin of 17.5% compared to 21.6% in Q4 2020.

    • Sub-Segments

      • The Trifork Inspire sub-segment revenue more than tripled to EURm 1.1 in Q4 2021 compared to Q4 2020, while the adjusted EBITDA amounted to EURm -0.1.

      • The Trifork Build sub-segment recorded a 17.9% revenue increase to EURm 32.0, from EURm 27.1 in Q4 2020 and an adjusted EBITDA margin of 19.6% compared to 15.4% in Q4 2020.

      • The Trifork Run sub-segment recorded a 20.2% revenue increase to EURm 8.9 and an adjusted EBITDA margin of 28.3% compared to 28.5% in Q4 2020.

  • Trifork Labs

    • Positive fair value adjustment of Trifork Labs investments was EURm 2.3. This came from unrealized gains as a result of new financing rounds and dividends. In 2020, fair value adjustments amounted to EURm 40.5, mainly due to the exit of the investment in Humio Ltd., that was agreed in December 2020, with proceeds received in March 2021.